METHOD FOR PREDICTION OF OUTCOME OF VIRAL PNEUMONIA IN COVID-19 Russian patent published in 2022 - IPC A61B5/91 A61B6/03 G01N33/68 G01N33/573 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to laboratory and radiation diagnostics, and can be used to predict the outcome of viral pneumonia in COVID-19. The level of albumin, lactate dehydrogenase in the blood, the affected and functioning lung volumes (ml) are determined, the coefficient K1, which characterizes the ratio of the affected to the functioning lung volume, is determined. When an albumin value of less than 27.5 g/l, K1 equal to or more than 1.95, a lactate dehydrogenase value equal to or more than 478 U/l, an unfavorable outcome of viral pneumonia in COVID-19 is predicted.

EFFECT: method makes it possible to increase the accuracy of predicting the outcome of viral pneumonia in COVID-19 by determining diagnostically significant indicators on the 3rd-55th day of hospitalization: lung volume - affected and functioning according to computed tomography, albumin and lactate dehydrogenase levels.

1 cl, 1 dwg, 5 ex